You think.
"Providing a complete abscopal response as seen in case study 1, potentially represents a new frontier in cancer therapy.
"http://www.noxopharm.com/irm/PDF/1520_1/EvidenceofAbscopalResponsesinPatients
Seems to be a lot of potential riding on case one. http://www.noxopharm.com/irm/PDF/1522_1/TROGAnnualScientificMeetingNoxopharmPresentation21318
The Abscopal Response Updated and Reviewed, page-10
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.5¢ | $5.635K | 48.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 649373 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 99714 | 1 |
View Market Depth
| Last trade - 10.14am 04/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |